10-116089914-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005264.8(GFRA1):c.1024A>G(p.Ile342Val) variant causes a missense change. The variant allele was found at a frequency of 0.000115 in 1,612,742 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005264.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000198 AC: 49AN: 246950Hom.: 0 AF XY: 0.000269 AC XY: 36AN XY: 133582
GnomAD4 exome AF: 0.000115 AC: 168AN: 1460504Hom.: 1 Cov.: 32 AF XY: 0.000172 AC XY: 125AN XY: 726454
GnomAD4 genome AF: 0.000112 AC: 17AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74428
ClinVar
Submissions by phenotype
Renal hypodysplasia/aplasia 4 Uncertain:1
The observed missense variant c.1024A>Gp.Ile342Val in the GFRA1 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is reported with the allele frequency 0.02% in the gnomAD Exomes. The amino acid Ile at position 342 is changed to a Val changing protein sequence and it might alter its composition and physico-chemical properties. Multiple lines of computational evidence Polyphen - Damaging, SIFT - Damaging and MutationTaster - Disease causing predict a damaging effect on protein structure and function for this variant. The residue is conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. A different missense variant in the same gene has been detected in the spouse. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at